|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：A791782 |
| 產(chǎn)品名稱：Atorvastatin-d5 Lactone |
| 產(chǎn)品CAS：1217749-86-4 |
| 規(guī)格含量：10mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
A791782 |
| 名稱: |
Atorvastatin-d5 Lactone |
| 別名: |
5-(4-Fluorophenyl)-2-(1-methylethyl)-N-phenyl-(4-phenyl-d5)-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-pyrrole-3-carboxamide; Atorvastatin-d5 δ-Lactone; |
| CAS號(hào): |
1217749-86-4 |
| 備用CAS: |
未標(biāo)記: 125995-03-1 |
| 分子式: |
C??H??D?FN?O? |
| 外觀: |
白色至淡黃色固體 |
| 熔點(diǎn): |
98-100°C |
| 分子量: |
545.66 |
| 儲(chǔ)存: |
-20°C Freezer, Under Inert Atmosphere |
| 溶解度: |
Methanol (Slightly), Ethyl Acetate (Slightly) |
| 類別: |
Standards; Isotopic Labeled Analogues; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Labelled Atorvastatin intermediate as inhibitor of MAP kinase and/or HMG-CoA reductase for the treatment of inflammation. |
| 文獻(xiàn) |
|
|
|
|
|
|
?您的位置：
